July 1, 2022 | By John Raslavsky | Cirrhosis, Clinical Research, NASH | Blog, Clinical trials, Fatty Liver Disease, liver health, Liver research
At their very root, non-alcoholic steatohepatitis (NASH) and cirrhosis are two medical conditions that affect the liver. However, this seemingly separate duo shares more in common than you may think. When NASH and cirrhosis get together, your liver is at …
May 31, 2022 | By John Raslavsky | Clinical Research, Jaundice, NASH | bilirubin and liver function, Blog, Clinical trials, Liver research, NASH Complications
Jaundice is a yellowing of the eye sclera (the white part) and skin because there’s too much bilirubin in the blood. There are many causes of jaundice. However, for people living with liver disease, jaundice is a common nonalcoholic steatohepatitis …
April 7, 2022 | By John Raslavsky | Clinical Trials, Liver Disease, Minority Participation in Liver Research | Blog, Diversity in research, Fatty Liver Disease, NAFLD, NASH, National Minority Health Month
April is National Minority Health Month (NMHM), a time to raise awareness about health disparities that affect people from racial and ethnic minority groups. Liver disease is growing in prevalence in the Hispanic population. It is also a leading cause …
February 28, 2022 | By John Raslavsky | Clinical Trials, Liver Health | Blog, liver disease research, NAFLD, NASH
There’s a lot of love to celebrate during the month of February. However, some of the things we love are bad for our overall health. One of these areas is our obsession with the “western diet,” which is high in …
January 31, 2022 | By John Raslavsky | Clinical Trials, Liver | Blog, liver health, Liver research, NAFLD, NASH
You can start this year on the right foot by taking proactive steps for your health and well-being. If you’ve been diagnosed with liver disease, keeping your liver healthy is essential. It’s a new year, and it’s time to set …
December 14, 2021 | By John Raslavsky | Clinical Research, PCOS | Blog, Hepatic Clinical Trials, liver health, NAFLD, NASH
The prevalence of non-alcoholic fatty liver disease (NAFLD), a condition that encompasses excess fat accumulation, inflammation, and liver scarring, is on the rise. Multiple factors go into developing NAFLD, and it has been linked to several other conditions. Polycystic ovary …
November 29, 2021 | By John Raslavsky | Clinical Research, NAFLD | Blog, Clinical trials, Fatty Liver Disease, liver health
In the medical world, we are always trying to find new ways to treat all kinds of conditions. Non-alcoholic fatty liver disease, or NAFLD, is a condition that we are constantly learning more about, especially in the work of clinical …
October 14, 2021 | By John Raslavsky | Clinical Trials, Fibroscan, Liver Awareness Month | Blog, NAFLD, NASH
The liver is one of the most vital organs in our bodies. It is impossible to survive without the life-sustaining functions it provides. Understandably, how well we take care of our liver impacts its ability to function properly. National Liver …
September 29, 2021 | By John Raslavsky | Cirrhosis, Fibroscan | Blog, Clinical trials, NAFLD, NASH
Cirrhosis of the liver is a progressive disease, developing slowly over many years. If allowed to continue, the buildup of scar tissue can eventually stop liver function. Because of the gradual decline, liver cirrhosis often goes undetected and unnoticed. You …
August 26, 2021 | By John Raslavsky | Cirrhosis, Clinical Trials, Liver Disease | Blog, NAFLD, NASH
Cirrhosis is when the permanent scarring of the liver has replaced the healthy tissue. While cirrhosis is most often associated with chronic alcohol consumption, it is brought about by many types of liver disease. Here’s how you get from liver disease …